Trevi Therapeutics (TRVI) PT Raised to $24 at Oppenheimer
Tweet Send to a Friend
(Updated - November 14, 2025 6:51 AM EST)
Oppenheimer analyst Leland Gershall raised the price target on Trevi Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershall raised the price target on Trevi Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
